(2,3-dihydroimidazo[2,1-b][1,3]thiazol-6-ylmethyl)amine dihydrochloride, 95.0%, 250mg

2,7-Dibromo-9,9-didecyl-9H-fluorene, 97%, 5g

Cyhalofop Butyl>97.0%(GC)25g

2-ACETYL-4-METHYLPHENYL 2-METHYLBENZOATE, 95.0%, 250mg

5-Chloro-2-fluorobenzoic Acid>98.0%(GC)(T)25g

6-Chloro-5-azaindole, 95.0%, 10g

Prolongación de vacío NS 14/23

Solución modificadora de matriz de nitrato de paladio, 2 g/L Pd(NO3)2 (99,999%) en HNO3 al 1%

1-(4-pyridinylmethyl)piperazine bis(trifluoroacetate), 95.0%, 250mg

(R)-4-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-2-(((benzyloxy)carbonyl)amino)butanoic acid, 95%, 25g

Palladium(II) Acetate Trimer>98.0%(T)5g

2-Amino-3-fluorobenzonitrile, 95.0%, 10g

2-(3,6-Bis(dimethylamino)xanthylium-9-yl)-5-carboxybenzoate, 95.0%, 1g